Aspar Pharmaceuticals recalls Ibuprofen 200mg Tablets due to foil perforations
Aspar Pharmaceuticals Ltd is recalling specific batches of Ibuprofen 200mg Tablets due to foil perforations in some blisters.
Company
Pharmaceutical intelligence for Aspar Pharmaceuticals Ltd with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.